https://scholars.lib.ntu.edu.tw/handle/123456789/566674
標題: | Recent advances in the study, prevention, and treatment of infectious diseases | 作者: | LI-MIN HUANG | 關鍵字: | Acquired immunodeficiency syndrome; Combinatorial chemistry; Human immunodeficiency virus; Polymerase chain reaction; Structure-based drug design; Vaccine | 公開日期: | 2000 | 卷: | 99 | 期: | 2 | 起(迄)頁: | 92-99 | 來源出版物: | Journal of the Formosan Medical Association | 摘要: | Along with the rapid progress in molecular biology and computer technology, many changes have occurred in the diagnosis, treatment, prevention, and understanding of infectious diseases. Molecular techniques are taking a more important role both ill the diagnosis and in the discovery of etiologic agents. The associations of Helicobacter priori with gastroduodenal disorders and Chlamydia pneumoniae with atherogenesis have revised contemporary thinking about the pathogenesis of chronic organ and tissue diseases. Vaccination, once a privilege of children, is now being used in adults and is also being tried as a therapeutic modality for chronic diseases. Acquired immunodeficiency syndrome (AIDS) has become pandemic and its toll is devastating. The study of AIDS has not only benefited patients living with human immunodeficiency virus (HIV) infection, but has also delivered a strong boost to antiviral research. Structure-based drug design was proven useful through the successful development of HIV protease inhibitors and an influenza neuraminidase inhibitor. In the future, the integration of structure-based drug design and combinatorial chemistry should expedite the pace of new drug development. Finally, dissection of human genes related to susceptibility to infectious diseases is a task to be completed in our fight against infectious microorganisms. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034112623&partnerID=40&md5=54a6fb32c5c1fe74699b7ee589930db8 https://scholars.lib.ntu.edu.tw/handle/123456789/566674 |
ISSN: | 0929-6646 | SDG/關鍵字: | proteinase inhibitor; sialidase inhibitor; acquired immune deficiency syndrome; atherogenesis; Chlamydophila pneumoniae; chronic disease; disease predisposition; drug design; drug structure; gastroduodenal ulcer; Helicobacter pylori; Human immunodeficiency virus 1; Human immunodeficiency virus infection; infection; pathogenesis; polymerase chain reaction; review; Acquired Immunodeficiency Syndrome; Communicable Disease Control; Communicable Diseases; Drug Design; Humans; Vaccination |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。